109 related articles for article (PubMed ID: 3045321)
41. Enzymatically inactive p60c-src mutant with altered ATP-binding site is fully phosphorylated in its carboxy-terminal regulatory region.
Jove R; Kornbluth S; Hanafusa H
Cell; 1987 Sep; 50(6):937-43. PubMed ID: 2441875
[TBL] [Abstract][Full Text] [Related]
42. Activation of Zap-70 tyrosine kinase due to a structural rearrangement induced by tyrosine phosphorylation and/or ITAM binding.
Visco C; Magistrelli G; Bosotti R; Perego R; Rusconi L; Toma S; Zamai M; Acuto O; Isacchi A
Biochemistry; 2000 Mar; 39(10):2784-91. PubMed ID: 10704231
[TBL] [Abstract][Full Text] [Related]
43. Isolation and characterization of temperature-sensitive mutants of Abelson murine leukaemia virus that exhibit dissociation among morphological transformation, soft agar colony-forming ability and tyrosine kinase activity.
Oka Y; Sugiyama H; Tsukada S; Shimizu Y; Inoue H; Hakura A; Kishimoto S
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2527-32. PubMed ID: 2550581
[TBL] [Abstract][Full Text] [Related]
44. Isolation of temperature-sensitive tyrosine kinase mutants of v-abl oncogene by screening with antibodies for phosphotyrosine.
Kipreos ET; Lee GJ; Wang JY
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1345-9. PubMed ID: 2434953
[TBL] [Abstract][Full Text] [Related]
45. Reversible dependence on growth factor interleukin-3 in myeloid cells expressing temperature sensitive v-abl oncogene.
Kipreos ET; Wang JY
Oncogene Res; 1988 Feb; 2(3):277-84. PubMed ID: 3259302
[TBL] [Abstract][Full Text] [Related]
46. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
Juang JL; Hoffmann FM
Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
[TBL] [Abstract][Full Text] [Related]
47. Cinnamamide analogs as inhibitors of protein tyrosine kinases.
Buzzetti F; Brasca MG; Crugnola A; Fustinoni S; Longo A; Penco S; Dalla Zonca P; Comoglio PM
Farmaco; 1993 May; 48(5):615-36. PubMed ID: 8343210
[TBL] [Abstract][Full Text] [Related]
48. Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.
Shore SK; Bogart SL; Reddy EP
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6502-6. PubMed ID: 2168550
[TBL] [Abstract][Full Text] [Related]
49. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
50. Conversion of a tyrosine kinase protein substrate to a high affinity ligand by ATP linkage.
Shen K; Cole PA
J Am Chem Soc; 2003 Dec; 125(52):16172-3. PubMed ID: 14692742
[TBL] [Abstract][Full Text] [Related]
51. Tyrosyl transfer ribonucleic acid synthetase from Escherichia coli B. Analysis of tyrosine and adenosine 5'-triphosphate binding sites.
Santi DV; Peńa VA
J Med Chem; 1973 Mar; 16(3):273-80. PubMed ID: 4581950
[No Abstract] [Full Text] [Related]
52. Synthesis and biochemical evaluation of a series of aminoflavones as potential inhibitors of protein-tyrosine kinases p56lck, EGFr, and p60v-src.
Cushman M; Zhu H; Geahlen RL; Kraker AJ
J Med Chem; 1994 Sep; 37(20):3353-62. PubMed ID: 7932563
[TBL] [Abstract][Full Text] [Related]
53. Steady state kinetics of spleen tyrosine kinase investigated by a real time fluorescence assay.
Papp E; Tse JK; Ho H; Wang S; Shaw D; Lee S; Barnett J; Swinney DC; Bradshaw JM
Biochemistry; 2007 Dec; 46(51):15103-14. PubMed ID: 18052078
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of Abelson oncogene function by erbstatin analogues.
Kawada M; Tawara J; Tsuji T; Honma Y; Hozumi M; Wang JY; Umezawa K
Drugs Exp Clin Res; 1993; 19(6):235-41. PubMed ID: 8013266
[TBL] [Abstract][Full Text] [Related]
55. Aspartyl phosphonates and phosphoramidates: the first synthetic inhibitors of bacterial aspartate-semialdehyde dehydrogenase.
Cox RJ; Gibson JS; Mayo Martín MB
Chembiochem; 2002 Sep; 3(9):874-86. PubMed ID: 12210989
[TBL] [Abstract][Full Text] [Related]
56. Expression, purification, and initial characterization of human Yes protein tyrosine kinase from a bacterial expression system.
Sun G; Budde RJ
Arch Biochem Biophys; 1997 Sep; 345(1):135-42. PubMed ID: 9281320
[TBL] [Abstract][Full Text] [Related]
57. Phosphonate-containing inhibitors of tyrosine-specific protein kinases.
Burke TR; Li ZH; Bolen JB; Marquez VE
J Med Chem; 1991 May; 34(5):1577-81. PubMed ID: 2033582
[TBL] [Abstract][Full Text] [Related]
58. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
Rosson D; Reddy EP
Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
[TBL] [Abstract][Full Text] [Related]
59. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso N; Frank DA; Griffin JD
J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
[TBL] [Abstract][Full Text] [Related]
60. Activation loop phosphorylation modulates Bruton's tyrosine kinase (Btk) kinase domain activity.
Lin L; Czerwinski R; Kelleher K; Siegel MM; Wu P; Kriz R; Aulabaugh A; Stahl M
Biochemistry; 2009 Mar; 48(9):2021-32. PubMed ID: 19206206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
